These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 12364353)

  • 1. Acute antihypertrophic actions of bradykinin in the rat heart: importance of cyclic GMP.
    Rosenkranz AC; Hood SG; Woods RL; Dusting GJ; Ritchie RH
    Hypertension; 2002 Oct; 40(4):498-503. PubMed ID: 12364353
    [TBL] [Abstract][Full Text] [Related]  

  • 2. B-type natriuretic peptide prevents acute hypertrophic responses in the diabetic rat heart: importance of cyclic GMP.
    Rosenkranz AC; Hood SG; Woods RL; Dusting GJ; Ritchie RH
    Diabetes; 2003 Sep; 52(9):2389-95. PubMed ID: 12941780
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antihypertrophic actions of the natriuretic peptides in adult rat cardiomyocytes: importance of cyclic GMP.
    Rosenkranz AC; Woods RL; Dusting GJ; Ritchie RH
    Cardiovasc Res; 2003 Feb; 57(2):515-22. PubMed ID: 12566124
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bradykinin blocks angiotensin II-induced hypertrophy in the presence of endothelial cells.
    Ritchie RH; Marsh JD; Lancaster WD; Diglio CA; Schiebinger RJ
    Hypertension; 1998 Jan; 31(1):39-44. PubMed ID: 9449388
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Angiotensin II-induced hypertrophy of adult rat cardiomyocytes is blocked by nitric oxide.
    Ritchie RH; Schiebinger RJ; LaPointe MC; Marsh JD
    Am J Physiol; 1998 Oct; 275(4):H1370-4. PubMed ID: 9746487
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ACE-inhibition induces NO-formation in cultured bovine endothelial cells and protects isolated ischemic rat hearts.
    Linz W; Wiemer G; Schölkens BA
    J Mol Cell Cardiol; 1992 Aug; 24(8):909-19. PubMed ID: 1331474
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ramiprilat enhances endothelial autacoid formation by inhibiting breakdown of endothelium-derived bradykinin.
    Wiemer G; Schölkens BA; Becker RH; Busse R
    Hypertension; 1991 Oct; 18(4):558-63. PubMed ID: 1655653
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of endothelium-derived bradykinin in the control of vascular tone.
    Hecker M; Dambacher T; Busse R
    J Cardiovasc Pharmacol; 1992; 20 Suppl 9():S55-61. PubMed ID: 1282631
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synergy of amlodipine and angiotensin-converting enzyme inhibitors in regulating myocardial oxygen consumption in normal canine and failing human hearts.
    Mital S; Loke KE; Slater JP; Addonizio L; Gersony WM; Hintze TH
    Am J Cardiol; 1999 Jun; 83(12A):92H-98H. PubMed ID: 10750596
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endothelial dysfunction limits the antihypertrophic action of bradykinin in rat cardiomyocytes.
    Rosenkranz AC; Dusting GJ; Ritchie RH
    J Mol Cell Cardiol; 2000 Jun; 32(6):1119-26. PubMed ID: 10888262
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhancement of cytosolic calcium, prostacyclin and nitric oxide by bradykinin and the ACE inhibitor ramiprilat in porcine brain capillary endothelial cells.
    Wiemer G; Popp R; Schölkens BA; Gögelein H
    Brain Res; 1994 Feb; 638(1-2):261-6. PubMed ID: 7515323
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Angiotensin-converting enzyme inhibitor ramiprilat interferes with the sequestration of the B2 kinin receptor within the plasma membrane of native endothelial cells.
    Benzing T; Fleming I; Blaukat A; Müller-Esterl W; Busse R
    Circulation; 1999 Apr; 99(15):2034-40. PubMed ID: 10209009
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Compensatory function of bradykinin B1 receptor in the inhibitory effect of captopril on cardiomyocyte hypertrophy and cardiac fibroblast proliferation in neonatal rats.
    Zou J; Ren JH; Feng D; Wang H; Xu J
    Chin Med J (Engl); 2008 Jul; 121(13):1220-5. PubMed ID: 18710643
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of bradykinin and nitric oxide in the cardioprotective action of ACE inhibitors.
    Hartman JC
    Ann Thorac Surg; 1995 Sep; 60(3):789-92. PubMed ID: 7545893
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Angiotensin-converting enzyme inhibitors unmask endogenous kinin production by bovine coronary artery endothelium.
    Hecker M; Bara AT; Busse R
    Eur Heart J; 1993 Nov; 14 Suppl I():161-3. PubMed ID: 8293768
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endothelium-derived bradykinin: implications for angiotensin-converting enzyme-inhibitor therapy.
    Busse R; Fleming I; Hecker M
    J Cardiovasc Pharmacol; 1993; 22 Suppl 5():S31-6. PubMed ID: 7508049
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Converting enzyme inhibitor-stimulated formation of nitric oxide and prostacyclin in endothelial cells from bovine aorta is mediated by endothelium-derived bradykinin.
    Wiemer G; Schölkens BA; Becker RH
    Agents Actions Suppl; 1992; 38 ( Pt 3)():196-200. PubMed ID: 1334350
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gene transfer of cGMP-dependent protein kinase I enhances the antihypertrophic effects of nitric oxide in cardiomyocytes.
    Wollert KC; Fiedler B; Gambaryan S; Smolenski A; Heineke J; Butt E; Trautwein C; Lohmann SM; Drexler H
    Hypertension; 2002 Jan; 39(1):87-92. PubMed ID: 11799084
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pretreatment with ramiprilat induces cardioprotection against free radical injury in guinea-pig isolated heart: involvement of bradykinin, protein kinase C and prostaglandins.
    Jin ZQ; Chen X
    Clin Exp Pharmacol Physiol; 2000 Apr; 27(4):257-62. PubMed ID: 10779122
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Potentiation of the vascular response to kinins by inhibition of myocardial kininases.
    Dendorfer A; Wolfrum S; Schäfer U; Stewart JM; Inamura N; Dominiak P
    Hypertension; 2000 Jan; 35(1 Pt 1):32-7. PubMed ID: 10642271
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.